Acetyl Coenzyme A Acetyltransferase 2 (ACAT2) Antibody

364€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Acetyl Coenzyme A Acetyltransferase 2 (ACAT2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx230073
tested applications
ELISA, WB, IHC, FCM, IP
Description
ACAT2 Antibody is a Rabbit Polyclonal against ACAT2.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Acetyl Coenzyme A Acetyltransferase 2 (ACAT2) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1/1000 - 1/5000, IHC: 1/20 - 1/200, IP: 1/200 - 1/2000. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purity | ≥ 95% (SDS-PAGE) |
Purification | Purified by immunogen affinity chromatography. |
Size 1 | 100 µg |
Form | Liquid |
Tested Applications | ELISA, WB, IHC, FCM, IP |
Buffer | PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol. |
Availability | Shipped within 5-12 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q9BWD1 |
Alias | ACAT2,Sterol O-acyltransferase 2 |
Background | Antibody anti-ACAT2 |
Status | RUO |
Note | Concentration: 2 mg/ml - Validity: 12 months. |
Descripción
ACAT2 is a cytosolic enzyme that is primarily expressed in the liver and intestine and is responsible for the esterification of cholesterol with long-chain fatty acids to form cholesteryl esters, which are then incorporated into lipoproteins such as very-low-density lipoproteins (VLDL) and chylomicrons. Unlike ACAT1, which is involved in mitochondrial ketone metabolism, ACAT2 plays a pivotal role in cholesterol homeostasis and lipid transport. It is essential for the packaging of cholesterol for transport through the bloodstream and is therefore crucial for maintaining lipid balance. Dysregulation of ACAT2 activity is associated with hypercholesterolemia and atherosclerosis, as increased cholesteryl ester formation can contribute to the formation of atherosclerotic plaques. Targeting ACAT2 has been explored as a potential therapeutic approach for reducing cholesterol levels and cardiovascular disease risk.
Related Products

Human ACAT2 (Acetyl Coenzyme A Acetyltransferase 2, cytosolic) ELISA Kit
Ver Producto
ACAT2 antibody
Ver Producto